Advertisement

Ads Placeholder
Loading...

Genfit S.A.

GNFT.PAEURONEXT
Healthcare
Biotechnology
8.63
0.00(0.00%)
U.S. Market opens in 54h 36m

Genfit S.A. Fundamental Analysis

Genfit S.A. (GNFT.PA) shows weak financial fundamentals with a PE ratio of -11.08, profit margin of -85.89%, and ROE of -63.70%. The company generates $0.0B in annual revenue with weak year-over-year growth of 1.35%.

Key Strengths

Cash Position25.03%
PEG Ratio0.00
Current Ratio3.74

Areas of Concern

ROE-63.70%
Operating Margin-61.75%
We analyze GNFT.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -98.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-98.3/100

We analyze GNFT.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

GNFT.PA struggles to generate sufficient returns from assets.

ROA > 10%
-17.89%

Valuation Score

Excellent

GNFT.PA trades at attractive valuation levels.

PE < 25
-11.08
PEG Ratio < 2
0.00

Growth Score

Weak

GNFT.PA faces weak or negative growth trends.

Revenue Growth > 5%
1.35%
EPS Growth > 10%
1.05%

Financial Health Score

Moderate

GNFT.PA shows balanced financial health with some risks.

Debt/Equity < 1
2.65
Current Ratio > 1
3.74

Profitability Score

Weak

GNFT.PA struggles to sustain strong margins.

ROE > 15%
-6369.97%
Net Margin ≥ 15%
-85.89%
Positive Free Cash Flow
No

Key Financial Metrics

Is GNFT.PA Expensive or Cheap?

P/E Ratio

GNFT.PA trades at -11.08 times earnings. This suggests potential undervaluation.

-11.08

PEG Ratio

When adjusting for growth, GNFT.PA's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Genfit S.A. at 8.19 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.19

EV/EBITDA

Enterprise value stands at -17.16 times EBITDA. This is generally considered low.

-17.16

How Well Does GNFT.PA Make Money?

Net Profit Margin

For every $100 in sales, Genfit S.A. keeps $-85.89 as profit after all expenses.

-85.89%

Operating Margin

Core operations generate -61.75 in profit for every $100 in revenue, before interest and taxes.

-61.75%

ROE

Management delivers $-63.70 in profit for every $100 of shareholder equity.

-63.70%

ROA

Genfit S.A. generates $-17.89 in profit for every $100 in assets, demonstrating efficient asset deployment.

-17.89%

Following the Money - Real Cash Generation

Operating Cash Flow

Genfit S.A. generates limited operating cash flow of $-3.18M, signaling weaker underlying cash strength.

$-3.18M

Free Cash Flow

Genfit S.A. generates weak or negative free cash flow of $-4.48M, restricting financial flexibility.

$-4.48M

FCF Per Share

Each share generates $-0.09 in free cash annually.

$-0.09

FCF Yield

GNFT.PA converts -1.04% of its market value into free cash.

-1.04%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.004

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

9.54

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.65

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.74

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.64

vs 25 benchmark

ROA

Return on assets percentage

-0.18

vs 25 benchmark

ROCE

Return on capital employed

-0.16

vs 25 benchmark

How GNFT.PA Stacks Against Its Sector Peers

MetricGNFT.PA ValueSector AveragePerformance
P/E Ratio-11.0828.45 Better (Cheaper)
ROE-63.70%763.00% Weak
Net Margin-85.89%-45265.00% (disorted) Weak
Debt/Equity2.650.34 Weak (High Leverage)
Current Ratio3.742795.60 Strong Liquidity
ROA-17.89%-16588.00% (disorted) Weak

GNFT.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Genfit S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

59.98%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

101.70%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

123.47%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ